216.520.1300 | InfoExpress@ExpressLinkGA.com | Login

Trump Signs “One Big Beautiful Bill Act” into Law

  • On July 8, 2025
By now, you’ve likely heard about the sweeping “One Big Beautiful Bill Act” (OBBB), recently passed by Congress and signed into law on July 4, 2025. While much of the coverage has focused on its tax and healthcare provisions, a lesser-known but highly impactful aspect of the legislation is its effect on employee benefits. The […]
Read More

Trump Administration Issues Final Rule Impacting the ACA’s Marketplace

  • On July 1, 2025
On June 25, 2025, the U.S. Department of Health and Human Services (HHS) published a final rule to implement new standards for the Affordable Care Act’s (ACA) Marketplaces (or Exchanges). According to HHS, improper Exchange enrollments, enabled by weakened verification processes and expanded premium subsidies, have triggered “widespread fraud.” The final rule’s changes are intended to address […]
Read More

Judge Overturns Biden-Era HIPAA Rule

  • On June 25, 2025
A federal judge in the Northern District of Texas invalidated an April 2024 regulation from the Department of Health and Human Services (HHS) that aimed to expand HIPAA’s privacy protections for reproductive health care. The rule, which took effect on December 23, 2024, prohibited health plans, providers, and their business associates from using or disclosing […]
Read More

U.S. Supreme Court Rejects Heightened Standard for Reverse Discrimination Claims

  • On June 10, 2025
On June 5, 2025, the U.S. Supreme Court issued a unanimous decision in Ames v. Ohio Department of Youth Services, holding that reverse discrimination claims do not require more evidence than standard discrimination claims. Instead, all discrimination claims are subject to the same evidentiary standard, regardless of whether the plaintiff is a member of a majority or minority group. […]
Read More

Trump Administration Rescinds Section 1557 Enforcement Guidance

  • On May 28, 2025
The U.S. Department of Health and Human Services (HHS) recently rescinded its Section 1557 interpretation and enforcement guidance from May 10, 2021, effective immediately. According to HHS, the rescission is part of an agency-wide initiative to reduce regulatory burdens in accordance with the Trump administration’s policies, and the guidance no longer represents the agency’s legal views. Background […]
Read More

Trump Administration Issues Executive Order Targeting Prescription Drug Costs

  • On May 19, 2025
On May 12, 2025, President Donald Trump issued an executive order (EO) that aims to bring the prices Americans pay for prescription drugs in line with those paid by similar nations. According to a White House fact sheet, the prices Americans pay for brand-name drugs are more than three times the price other nations pay. In April, President […]
Read More

Trump Administration Reconsiders Enforcement of Final Mental Health Parity Rule

  • On May 19, 2025
On May 15, 2025, the U.S. Departments of Labor, Health and Human Services, and the Treasury (Departments) released a statement regarding nonenforcement of the 2024 final rule under the Mental Health Parity and Addiction Equity Act (MHPAEA). The statement relates to a lawsuit by an employer trade group seeking to invalidate the final rule. The litigation has been put […]
Read More

Trump Administration Executive Order Aimed at Prescription Drug Prices

  • On May 7, 2025
On April 15, 2025, President Trump issued an executive order (EO) to lower prescription drug prices for health plan participants and beneficiaries. The EO covered various issues, such as enhancing price transparency, reforming pharmacy benefit managers (PBMs), and boosting competition to lower prescription drug costs. PBM Reform and Compensation Disclosure The EO directs the Department of Health […]
Read More